drugset / Trial / NCT06888479
Optimal Timing of Hepatitis B Vaccination After Transplants
RandomizedFactorialOpen-labelPrevention
Summary
The investigators aim to perform a randomized clinical trial to determine the optimal timing of hepatitis B vaccination after hematopoietic cell transplantation (HCT) through evaluating the immunity effect of two different vaccination schedules (initiated at 3 or 6 months after transplantation) in patients with different immune reconstitution status.
Timeline
- Start
- 2025-06-01
- Primary completion
- 2028-06-01
- Completion
- 2029-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hepatitis B vaccine | Vaccine | — | — |